Asimov
Asimov is seeking a technical expert to lead viral vector process engineering for gene therapies, focusing on lentiviral and adeno-associated viral vector workflows. The role involves designing complex experiments, optimizing bioreactor processes, and collaborating with cross-functional teams to advance next-generation therapeutics. This position offers a unique opportunity to contribute to a forward-thinking synthetic biology startup.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2017
Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Asimov.
Viral Vector Manufacturing Process Development Intern
UCB
Viral Vector Manufacturing Process Development Intern
UCB
Director Vector Engineering
AstraZeneca
Upstream Principal Scientist, Vector Biology
Legend Biotech
BioProcess Engineer II, Upstream
ImmunityBio
Exec Director, Viral Vector Process Development
Gilead Sciences